News - Midlands
Anaxsys gets early advantage
A West Midlands medical technology has become the first recipient of investment from the newly launched Early Advantage Fund, managed by Birmingham-based Midven. Anaxsys Technology of Keele, Staffordshire, is developing devices that enable the diagnosis and monitoring of a variety of diseases by analysing the humidity profile of breath. The Early Advantage Fund is investing £125,000 as part of a £500,000 investment round that will allow the company to conduct clinical trials prior to launching its first product later in 2010. The investment was announced at the official launch of the Early Advantage Fund, which is backed by Advantage West Midlands and the European Regional Development Fund.